Home
/
ORAGENICS INC
/
Financials
/
Quarterly
ORAGENICS INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that ORAGENICS INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2018
Sep 30, 2018
$0
Nov 13, 2018
Q2
2018
Jun 30, 2018
$0
Aug 13, 2018
Q1
2018
Mar 31, 2018
$0
May 15, 2018
Q3
2017
Sep 30, 2017
$0
Oct 31, 2017
Q2
2017
Jun 30, 2017
$0
Aug 14, 2017
Q2
2015
Jun 30, 2015
$242.0K
Aug 7, 2015
Q1
2015
Mar 31, 2015
$363.8K
May 8, 2015
Q3
2014
Sep 30, 2014
$201.0K
Nov 3, 2014
Q2
2015
Jun 30, 2014
$303.8K
Aug 7, 2015
Q1
2015
Mar 31, 2014
$214.7K
May 8, 2015
Q3
2014
Sep 30, 2013
$253.4K
Nov 3, 2014
Q2
2014
Jun 30, 2013
$167.7K
Aug 7, 2014
Q1
2014
Mar 31, 2013
$176.4K
May 9, 2014
Q3
2013
Sep 30, 2012
$264.2K
Oct 25, 2013
Q2
2013
Jun 30, 2012
$256.4K
Aug 12, 2013
Q1
2013
Mar 31, 2012
$380.5K
May 15, 2013
Q3
2012
Sep 30, 2011
$350.4K
Nov 14, 2012
Q2
2012
Jun 30, 2011
$347.6K
Aug 10, 2012
Q1
2012
Mar 31, 2011
$349.9K
May 15, 2012
Q3
2011
Sep 30, 2010
$364.6K
Nov 14, 2011
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2023
$7.5K
Nov 13, 2024
Q2
2024
Jun 30, 2023
$13.2K
Aug 9, 2024
Q1
2024
Mar 31, 2023
$17.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$86.0K
Nov 9, 2023
Q2
2023
Jun 30, 2022
$30.4K
Aug 11, 2023
Q1
2023
Mar 31, 2022
$15.1K
May 12, 2023
Revenue (Net Sales) — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2016
Sep 30, 2016
$0
Nov 14, 2016
Q2
2016
Jun 30, 2016
$0
Aug 15, 2016
Q1
2016
Mar 31, 2016
$262.3K
May 16, 2016
Q3
2016
Sep 30, 2015
$0
Nov 14, 2016
Q2
2016
Jun 30, 2015
$0
Aug 15, 2016
Q1
2016
Mar 31, 2015
$363.8K
May 16, 2016
Q3
2015
Sep 30, 2014
$201.0K
Nov 6, 2015
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.07M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($2.27M)
Aug 8, 2025
Q3
2025
Jun 30, 2025
($2.27M)
Nov 7, 2025
Q2
2025
Mar 31, 2025
($2.22M)
Aug 8, 2025
Q3
2025
Mar 31, 2025
($2.22M)
Nov 7, 2025
Q1
2025
Mar 31, 2025
($2.22M)
May 9, 2025
Q3
2025
Sep 30, 2024
($2.46M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($2.31M)
Aug 8, 2025
Q3
2025
Jun 30, 2024
($2.31M)
Nov 7, 2025
Q2
2025
Mar 31, 2024
($2.45M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($2.45M)
May 9, 2025
Q3
2025
Mar 31, 2024
($2.45M)
Nov 7, 2025
Q3
2024
Sep 30, 2023
($2.01M)
Nov 13, 2024
Q3
2024
Jun 30, 2023
($3.05M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.05M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($2.84M)
May 15, 2024
Q2
2024
Mar 31, 2023
($2.84M)
Aug 9, 2024
Q3
2024
Mar 31, 2023
($2.84M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($3.87M)
Nov 9, 2023
Q3
2023
Jun 30, 2022
($3.59M)
Nov 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.12M)
Nov 7, 2025
Q2
2025
Jun 30, 2025
($1.71M)
Aug 8, 2025
Q1
2025
Mar 31, 2025
($2.03M)
May 9, 2025
Q3
2025
Sep 30, 2024
($2.44M)
Nov 7, 2025
Q2
2025
Jun 30, 2024
($2.31M)
Aug 8, 2025
Q1
2025
Mar 31, 2024
($2.46M)
May 9, 2025
Q3
2024
Sep 30, 2023
($2.09M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($3.11M)
Aug 9, 2024
Q1
2024
Mar 31, 2023
($2.90M)
May 15, 2024
Q3
2023
Sep 30, 2022
($3.91M)
Nov 9, 2023
Q2
2023
Jun 30, 2022
($3.60M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($4.61M)
May 12, 2023
Q3
2022
Sep 30, 2021
($4.39M)
Apr 14, 2023
Q2
2022
Jun 30, 2021
($3.84M)
Apr 14, 2023
Q1
2022
Mar 31, 2021
($5.24M)
Apr 14, 2023
Q3
2021
Sep 30, 2020
($4.51M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($12.35M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($5.23M)
May 3, 2021
Q3
2020
Sep 30, 2019
($3.92M)
Nov 10, 2020
Q2
2020
Jun 30, 2019
($4.90M)
Aug 14, 2020